Isofol Medical AB (FRA:5IU) YoY EBITDA Growth : 37.50% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Isofol Medical AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Isofol Medical AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 37.50%.

Isofol Medical AB's EBITDA per Share for the three months ended in Mar. 2024 was €-0.01.

Isofol Medical AB YoY EBITDA Growth Historical Data

The historical data trend for Isofol Medical AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB YoY EBITDA Growth Chart

Isofol Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-90.43

-36.53

48.49

41.56

77.78

Isofol Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															72.41	87.10	83.33	64.29	37.50

Isofol Medical AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Isofol Medical AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.02	-	-0.09)	/	\| -0.09 \|
=	77.78 %

Isofol Medical AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.005	-	-0.008)	/	\| -0.008 \|
=	37.50 %

Isofol Medical AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Isofol Medical AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Isofol Medical AB (FRA:5IU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (FRA:5IU) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

ISOFOL:Sweden

Address

Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46

Website

http://www.isofol.se

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (FRA:5IU) Headlines

No Headlines